NNNN Short Volume

Anbio Biotechnology Class A Ordinary Shares (NNNN) operates in the Healthcare sector, specifically the Medical - Instruments & Supplies industry, with a market capitalization near $336.6M, listed on NASDAQ, employing roughly 27 people, carrying a beta of 5.35 to the broader market. Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. Led by Michael Lau, public since 2025-02-19.

Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.

Latest Date
2026-08-28
Short Volume
86.4K
Total Volume
128.1K
Short %
67.45%
30-Day Avg Short %
47.86%

Showing 30 days of FINRA short volume data for Anbio Biotechnology Class A Ordinary Shares.

Learn how short volume is reported and how to read the data →

Frequently asked NNNN short volume questions

What is the daily NNNN short volume?
As of Aug 28, 2026, Anbio Biotechnology Class A Ordinary Shares (NNNN) short volume is 86.4K shares against 128.1K total reported volume, or 67.45% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
How is NNNN short volume reported?
FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
What does NNNN short volume tell options traders?
Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.